Literature DB >> 22699511

NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis.

Makoto Inoue1, Kristi L Williams, Michael D Gunn, Mari L Shinohara.   

Abstract

The NLRP3 inflammasome is a multiprotein complex consisting of three kinds of proteins, NLRP3, ASC, and pro-caspase-1, and plays a role in sensing pathogens and danger signals in the innate immune system. The NLRP3 inflammasome is thought to be involved in the development of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). However, the mechanism by which the NLRP3 inflammasome induces EAE is not clear. In this study, we found that the NLRP3 inflammasome played a critical role in inducing T-helper cell migration into the CNS. To gain migratory ability, CD4(+) T cells need to be primed by NLRP3 inflammasome-sufficient antigen-presenting cells to up-regulate chemotaxis-related proteins, such as osteopontin, CCR2, and CXCR6. In the presence of the NLRP3 inflammasome, dendritic cells and macrophages also induce chemotactic ability and up-regulate chemotaxis-related proteins, such as α4β1 integrin, CCL7, CCL8, and CXCL16. On the other hand, reduced Th17 cell population size in immunized Nlrp3(-/-) and Asc(-/-) mice is not a determinative factor for their resistance to EAE. As currently applied in clinical interventions of MS, targeting immune cell migration molecules may be an effective approach in treating MS accompanied by NLRP3 inflammasome activation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22699511      PMCID: PMC3387125          DOI: 10.1073/pnas.1201836109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Regional neural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier.

Authors:  Yasunobu Arima; Masaya Harada; Daisuke Kamimura; Jin-Haeng Park; Fuminori Kawano; Fiona E Yull; Tadafumi Kawamoto; Yoichiro Iwakura; Ulrich A K Betz; Gabriel Márquez; Timothy S Blackwell; Yoshinobu Ohira; Toshio Hirano; Masaaki Murakami
Journal:  Cell       Date:  2012-02-03       Impact factor: 41.582

2.  NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses.

Authors:  Denis Gris; Zhengmao Ye; Heather A Iocca; Haitao Wen; Robin R Craven; Pavel Gris; Max Huang; Monika Schneider; Stephen D Miller; Jenny P-Y Ting
Journal:  J Immunol       Date:  2010-06-23       Impact factor: 5.422

3.  The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18.

Authors:  Sushmita Jha; Siddharth Y Srivastava; W June Brickey; Heather Iocca; Arrel Toews; James P Morrison; Vivian S Chen; Denis Gris; Glenn K Matsushima; Jenny P-Y Ting
Journal:  J Neurosci       Date:  2010-11-24       Impact factor: 6.167

Review 4.  Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases.

Authors:  Toshimitsu Uede
Journal:  Pathol Int       Date:  2011-03-08       Impact factor: 2.534

5.  Molecular characterization and evaluation of virulence factors of Cryptococcus laurentii and Cryptococcus neoformans strains isolated from external hospital areas.

Authors:  Leonardo Andrade-Silva; Kennio Ferreira-Paim; Mario León Silva-Vergara; André Luiz Pedrosa
Journal:  Fungal Biol       Date:  2010-03-10

6.  Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity.

Authors:  Stephen J Lalor; Lara S Dungan; Caroline E Sutton; Sharee A Basdeo; Jean M Fletcher; Kingston H G Mills
Journal:  J Immunol       Date:  2011-04-06       Impact factor: 5.422

7.  TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology.

Authors:  Mandy J McGeachy; Kristian S Bak-Jensen; Yi Chen; Cristina M Tato; Wendy Blumenschein; Terrill McClanahan; Daniel J Cua
Journal:  Nat Immunol       Date:  2007-11-11       Impact factor: 25.606

8.  Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin.

Authors:  Mari L Shinohara; June-Ho Kim; Virgilio A Garcia; Harvey Cantor
Journal:  Immunity       Date:  2008-07-18       Impact factor: 31.745

9.  Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAE.

Authors:  Veit Rothhammer; Sylvia Heink; Franziska Petermann; Rajneesh Srivastava; Malte C Claussen; Bernhard Hemmer; Thomas Korn
Journal:  J Exp Med       Date:  2011-10-24       Impact factor: 14.307

10.  The inflammasome adaptor ASC regulates the function of adaptive immune cells by controlling Dock2-mediated Rac activation and actin polymerization.

Authors:  Sirish K Ippagunta; R K Subbarao Malireddi; Patrick J Shaw; Geoffrey A Neale; Lieselotte Vande Walle; Douglas R Green; Yoshinori Fukui; Mohamed Lamkanfi; Thirumala-Devi Kanneganti
Journal:  Nat Immunol       Date:  2011-09-04       Impact factor: 25.606

View more
  115 in total

Review 1.  Inflammasomes in the CNS.

Authors:  John G Walsh; Daniel A Muruve; Christopher Power
Journal:  Nat Rev Neurosci       Date:  2014-01-08       Impact factor: 34.870

Review 2.  Inflammasomes and adaptive immune responses.

Authors:  Katherine A Deets; Russell E Vance
Journal:  Nat Immunol       Date:  2021-02-18       Impact factor: 25.606

3.  TLR-stimulated IRAKM activates caspase-8 inflammasome in microglia and promotes neuroinflammation.

Authors:  Cun-Jin Zhang; Meiling Jiang; Hao Zhou; Weiwei Liu; Chenhui Wang; Zizhen Kang; Bing Han; Quanri Zhang; Xing Chen; Jianxin Xiao; Amanda Fisher; William J Kaiser; Masanori A Murayama; Yoichiro Iwakura; Ji Gao; Julie Carman; Ashok Dongre; George Dubyak; Derek W Abbott; Fu-Dong Shi; Richard M Ransohoff; Xiaoxia Li
Journal:  J Clin Invest       Date:  2018-10-29       Impact factor: 14.808

4.  Cutting edge: Role of osteopontin and integrin αv in T cell-mediated anti-inflammatory responses in endotoxemia.

Authors:  Makoto Inoue; Mari L Shinohara
Journal:  J Immunol       Date:  2015-05-13       Impact factor: 5.422

5.  NLRP3 inflammasome is associated with the response to IFN-β in patients with multiple sclerosis.

Authors:  Sunny Malhotra; Jordi Río; Elena Urcelay; Ramil Nurtdinov; Marta F Bustamante; Oscar Fernández; Begoña Oliver; Uwe Zettl; David Brassat; Joep Killestein; Jeannette Lechner-Scott; Jelena Drulovic; Andrew Chan; Filippo Martinelli-Boneschi; Antonio García-Merino; Xavier Montalban; Manuel Comabella
Journal:  Brain       Date:  2015-01-12       Impact factor: 13.501

6.  An interferon-β-resistant and NLRP3 inflammasome-independent subtype of EAE with neuronal damage.

Authors:  Makoto Inoue; Po-Han Chen; Stephen Siecinski; Qi-Jing Li; Chunlei Liu; Lawrence Steinman; Simon G Gregory; Eric Benner; Mari L Shinohara
Journal:  Nat Neurosci       Date:  2016-11-07       Impact factor: 24.884

Review 7.  Inflammasomes link vascular disease with neuroinflammation and brain disorders.

Authors:  Nikolett Lénárt; David Brough; Ádám Dénes
Journal:  J Cereb Blood Flow Metab       Date:  2016-08-02       Impact factor: 6.200

8.  Targeting macrophages by an aza-anthrapyrazole to ameliorate experimental autoimmune encephalomyelitis.

Authors:  Boren Lin; Dylan Launder; Destiny Y Bailey; Frank K Assifuah; Olivia A Miller; Heather R Conti; Jianyang Du; Boyd M Koffman
Journal:  Mult Scler Relat Disord       Date:  2020-05-16       Impact factor: 4.339

9.  The nucleotide-binding leucine-rich repeat (NLR) family member NLRX1 mediates protection against experimental autoimmune encephalomyelitis and represses macrophage/microglia-induced inflammation.

Authors:  Timothy K Eitas; Wei-Chun Chou; Haitao Wen; Denis Gris; Gregory R Robbins; June Brickey; Yoshitaka Oyama; Jenny P-Y Ting
Journal:  J Biol Chem       Date:  2013-12-23       Impact factor: 5.157

Review 10.  Close Encounters of the First Kind: Innate Sensors and Multiple Sclerosis.

Authors:  Lidia Fernández-Paredes; Rebeca Pérez de Diego; Clara de Andrés; Silvia Sánchez-Ramón
Journal:  Mol Neurobiol       Date:  2016-01-05       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.